» Articles » PMID: 2828022

Structural Features Required for Ligand Binding to the Beta-adrenergic Receptor

Overview
Journal EMBO J
Date 1987 Nov 1
PMID 2828022
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

On the basis of the homology between the amino acid sequences of the beta-adrenergic receptor (beta AR) and the opsin proteins we have proposed that the ligand binding domain lies within the seven transmembrane hydrophobic regions of the protein, which are connected by hydrophilic regions alternatively exposed extracellularly and intracellularly. We have systematically examined the importance of each of these regions by making a sequential series of deletions in the gene for the hamster beta AR which encompass most of the protein coding region. The ability of the corresponding mutant receptors to be expressed, localized to the cell membrane, and bind beta-adrenergic ligands has been analyzed, using transient expression in COS-7 cells. The hydrophobic regions and the hydrophilic segments immediately adjacent to the membrane cannot be removed without affecting the processing and membrane localization of the beta AR. However, most of the hydrophilic regions appear to be dispensable for ligand binding. In addition, we observed that substitution of the conserved cysteine residues at positions 106 and 184 dramatically altered the ligand binding characteristics of the beta AR, suggesting the occurrence of a disulfide bond between these two residues in the native protein. These data are discussed in terms of the tertiary structure of the beta AR.

Citing Articles

Generation of full-length cDNAs for eight putative GPCnR from the cattle tick, R. microplus using a targeted degenerate PCR and sequencing strategy.

Corley S, Piper E, Jonsson N PLoS One. 2012; 7(3):e32480.

PMID: 22403662 PMC: 3293813. DOI: 10.1371/journal.pone.0032480.


Receptor chimeras demonstrate that the C-terminal domain of the human cytomegalovirus US27 gene product is necessary and sufficient for intracellular receptor localization.

Stapleton L, Arnolds K, Lares A, Devito T, Spencer J Virol J. 2012; 9:42.

PMID: 22339884 PMC: 3298792. DOI: 10.1186/1743-422X-9-42.


A "genome-to-lead" approach for insecticide discovery: pharmacological characterization and screening of Aedes aegypti D(1)-like dopamine receptors.

Meyer J, Ejendal K, Avramova L, Garland-Kuntz E, Giraldo-Calderon G, Brust T PLoS Negl Trop Dis. 2012; 6(1):e1478.

PMID: 22292096 PMC: 3265452. DOI: 10.1371/journal.pntd.0001478.


Molecular Architecture of G Protein-Coupled Receptors.

van Rhee A, Jacobson K Drug Dev Res. 2011; 37(1):1-38.

PMID: 21921973 PMC: 3171971. DOI: 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S.


Structural insights into adrenergic receptor function and pharmacology.

Kobilka B Trends Pharmacol Sci. 2011; 32(4):213-8.

PMID: 21414670 PMC: 3090711. DOI: 10.1016/j.tips.2011.02.005.


References
1.
Dixon R, Sigal I, Rands E, Register R, Candelore M, Blake A . Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core. Nature. 1987; 326(6108):73-7. DOI: 10.1038/326073a0. View

2.
Peralta E, Winslow J, Peterson G, Smith D, Ashkenazi A, Ramachandran J . Primary structure and biochemical properties of an M2 muscarinic receptor. Science. 1987; 236(4801):600-5. DOI: 10.1126/science.3107123. View

3.
Strader C, Sigal I, Blake A, Cheung A, Register R, Rands E . The carboxyl terminus of the hamster beta-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration. Cell. 1987; 49(6):855-63. DOI: 10.1016/0092-8674(87)90623-4. View

4.
Strader C, Sigal I, Register R, Candelore M, Rands E, Dixon R . Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1987; 84(13):4384-8. PMC: 305093. DOI: 10.1073/pnas.84.13.4384. View

5.
Munson P, Rodbard D . Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980; 107(1):220-39. DOI: 10.1016/0003-2697(80)90515-1. View